These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 19730451)
21. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells. Chao JI; Liu HF Mol Pharmacol; 2006 Jan; 69(1):154-64. PubMed ID: 16219911 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells. Chen T; Deng C Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912 [TBL] [Abstract][Full Text] [Related]
23. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer. Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673 [TBL] [Abstract][Full Text] [Related]
24. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621 [TBL] [Abstract][Full Text] [Related]
25. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156 [TBL] [Abstract][Full Text] [Related]
26. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317 [TBL] [Abstract][Full Text] [Related]
27. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells. Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881 [TBL] [Abstract][Full Text] [Related]
28. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
29. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector. Rohr UP; Wulf MA; Stahn S; Heyd F; Steidl U; Fenk R; Opalka B; Pitschke G; Prisack HB; Bojar H; Haas R; Kronenwett R Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316 [TBL] [Abstract][Full Text] [Related]
31. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin. Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792 [TBL] [Abstract][Full Text] [Related]
32. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo. Zhang K; Li Y; Liu W; Gao X; Zhang K Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812 [TBL] [Abstract][Full Text] [Related]
33. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567 [TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo. Grimes KR; Warren GW; Fang F; Xu Y; St Clair WH Oncol Rep; 2006 Oct; 16(4):771-6. PubMed ID: 16969492 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu. Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104 [TBL] [Abstract][Full Text] [Related]
36. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168 [TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated siRNA inhibited survivin gene expression induces tumor cell apoptosis in nude mice. Yin K; Liu Q; Zhu S; Yan G Biosci Trends; 2008 Dec; 2(6):231-4. PubMed ID: 20103933 [TBL] [Abstract][Full Text] [Related]
38. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
39. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression. Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876 [TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]